To the extent possible under law, the person who associated CC0 with this work has waived all copyright and related or neighboring rights to this work.
| DRAVP ID | Peptide Name | Source | Target Organism | Patent No |
|---|---|---|---|---|
| DRAVPa2461 | Sequence 1 from Patent CN117886901A | Synthetic construct | AIV | CN117886901A |
| DRAVPa2462 | Sequence 2 from Patent CN117886901A | Synthetic construct | AIV | CN117886901A |
| DRAVPa2463 | Sequence 3 from Patent CN117886901A | Synthetic construct | AIV | CN117886901A |
| DRAVPa2464 | Sequence 4 from Patent CN117886901A | Synthetic construct | AIV | CN117886901A |
| DRAVPa2465 | Sequence 1 from Patent CN117843735A | Synthetic construct | SARS-CoV-2 | CN117843735A |
| DRAVPa2466 | Glutathione | Synthetic construct | BmNPV | CN117257914B |
To the extent possible under law, the person who associated CC0 with this work has waived all copyright and related or neighboring rights to this work.